biopharmaceutical

Welcome to the 'biopharmaceutical' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'biopharmaceutical'.

Latest blogosphere posts tagged “biopharmaceutical”

• Novartis buys into Chinese vaccine maker

  
  GenevaLunch — Authority: 448
  Novartis on the Rhine, at Basel © Novartis AG Basel, Switzerland (GenevaLunch) - Swiss drugs maker, Novartis, has acquired 85 percent of Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co. for $125 million, subject to government approval, the company announced 4 November. Tianyuan is a privately held ...
  4 days ago

• Is Big Pharma Choosing Patients over Patents?

  
  PharmTech Talk — Authority: 120
  The pharmaceutical and biopharmaceutical industries have jealously guarded their intellectual property for years. Companies routinely use patents to prevent competitors from making generic versions of their drugs. When pipelines have weakened, companies have developed new formulations or delivery methods to extend ...
  1 week ago

• NeoCutis Acknowledges Cultivating Skin Creams from Aborted Fetus

  
  Front Page — Authority: 127
  A cosmetics manufacturer admits that it is using aborted fetal cell lines in a line of anti-aging skin creams.NeoCutis, a Switzerland-based bio-pharmaceutical company with offices in San Francisco, is using Processed Skin Cell Protein, or PSP, an ingredient developed from skin cells harvested from an aborted fetus. ...
  1 week ago

• INTUNIV demonstrated symptom reduction on oppositional subscale Conners ADHD rating scale

  
  Science Blog - Science news straight from the source — Authority: 612
  HONOLULU - October 29, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV? (guanfacine) Extended Release Tablets, a
  1 week ago

• Shire presents study findings on its ADHD treatments at psychiatric meeting Oct 29-30

  
  Science Blog - Science news straight from the source — Authority: 612
  HONOLULU -- October 29, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Defi
  1 week ago

• Catalent Develops New Decorin Molecule Form, Strikes Deal With Euclid

  
  EPR Network Blog — Authority: 146
  Released on: October 23, 2009, 7:46 amAuthor: Jennings and Co.Industry: PharmaceuticalsSOMERSET, NJ -Catalent Pharma Solutions, a leading provider of advanced technologies and outsourced development and clinical services to the global pharmaceutical andbiotechnology industry, has announced the development of the ...
  2 weeks ago

• Targacepts P.2b depression study succeeds: 6-point difference on HAM-D

  
  Science Blog - Science news straight from the source — Authority: 612
  Targacept, Inc.
  3 weeks ago

• Science Magazine Survey: American Life Sciences Companies are Some of the Best to Work for in the World

  
  Bio Job Blog — Authority: 470
  An annual survey conducted by Science magazine and the American Association has identified the 2008 top twenty life sciences employers in the world. The rankings were based on a company’s leadership, stability, social responsibility and treatment of its employees. Six of the top 10— Genentech, Gilead Sciences, ...
  3 weeks ago

• Adhezion Biomedical, LLC

  
  advanced medical technologies — Authority: 127
  Below is a brief profile of Adhezion Biomedical, LLC, one of the companies active in the surgical sealants and glues market and profiled in the MedMarket Diligence report #S175 .  We occasionally highlight companies whose products, in our opinion, are poised to make an impact on medtech markets. Founded in 2001, ...
  3 weeks ago

• Hemostats market: dominant players, but many competitors

  
  advanced medical technologies — Authority: 127
  Hemostats have been used for over a hundred years to stop bleeding in surgical and traumatic wounds. Primarily these products were first introduced to prevent hematomas during surgery with the aim of preventing resultant infections. During the 1980s and 1990s, the popularity of hemostats increased rapidly as surgeons ...
  3 weeks ago

• Stem Cells Get a Big Boost from a Small Molecule

  
  PharmTech Talk — Authority: 120
  The pace of progress in stem-cell research seems to be quickening, and the field’s future looks promising. Last week, a team at the Harvard Stem Cell Institute found what looks like a revolutionary way to create stem cells that could be safe enough to use as treatments in humans. Let’s recap a few major ...
  4 weeks ago

Comments about biopharmaceutical